Medical imaging software developer ISG Technologies has named Max Rutherford president and COO of the Mississauga, Ontario, company. Rutherford fills a position once held by Thomas Cafarella, the former ISG executive who participated in a takeover bid
Medical imaging software developer ISG Technologies has named Max Rutherford president and COO of the Mississauga, Ontario, company. Rutherford fills a position once held by Thomas Cafarella, the former ISG executive who participated in a takeover bid for ISG after he was released from the company last year (SCAN 1/8/97).
Rutherford comes to ISG from CAE Electronics, a flight-simulator company, where his last two posts were vice president of business development and vice president of engineering. ISG got its start as a flight-simulator developer before shifting to medical imaging.
Rutherford will be responsible for ISG's business units and operations groups. He will report to Dr. Michael Greenberg, who remains ISG's chairman and CEO.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.